相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Identification of antibiotic pairs that evade concurrent resistance via a retrospective analysis of antimicrobial susceptibility test results
Andrew M. Beckley et al.
LANCET MICROBE (2021)
Ceftazidime-Avibactam Resistance Mediated by the N346Y Substitution in Various AmpC β-Lactamases
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Molecular Epidemiology and Antimicrobial Resistance of Haemophilus influenzae in Adult Patients in Shanghai, China
Xin-Xin Li et al.
FRONTIERS IN PUBLIC HEALTH (2020)
Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen
Alicia Fajardo-Lubian et al.
PLOS PATHOGENS (2019)
Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network
Nathaniel J. Rhodes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories
Romney M. Humphries et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia
Wang-Da Liu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2019)
Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
Vincent Trebosc et al.
MBIO (2019)
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
Joshua L. C. Wong et al.
NATURE COMMUNICATIONS (2019)
Trends in Antimicrobial Drug Resistance of Streptococcus pneumoniae Isolates at Jordan University Hospital (2000-2018)
Malik Sallam et al.
ANTIBIOTICS-BASEL (2019)
MIC-based dose adjustment: facts and fables
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014
Sanjat Kanjilal et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15
James A. Karlowsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Drug-mediated metabolic tipping between antibiotic resistant states in a mixed-species community
Robert E. Beardmore et al.
NATURE ECOLOGY & EVOLUTION (2018)
Assessment of Doripenem, Meropenem, and Imipenem against Respiratory Isolates of Pseudomonas aeroginosa in a Tertiary Care Hospital of North India
Arti Negi et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2017)
Unusual Escherichia coli PBP 3 Insertion Sequence Identified from a Collection of Carbapenem-Resistant Enterobacteriaceae Tested In Vitro with a Combination of Ceftazidime-, Ceftaroline-, or Aztreonam-Avibactam
Yunliang Zhang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Relative contribution of biological variation and technical variables to zone diameter variations of disc diffusion susceptibility testing
Michael Hombach et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
Meredith Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective
Lindsay Kim et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae
Alex Agyekum et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2016)
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?
Marlieke E. A. de Kraker et al.
PLOS MEDICINE (2016)
Temporal variation in antibiotic environments slows down resistance evolution in pathogenic Pseudomonas aeruginosa
Roderich Roemhild et al.
EVOLUTIONARY APPLICATIONS (2015)
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission
D. Lepelletier et al.
JOURNAL OF HOSPITAL INFECTION (2015)
AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity
Jessica M. A. Blair et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Using a Sequential Regimen to Eliminate Bacteria at Sublethal Antibiotic Dosages
Ayari Fuentes-Hernandez et al.
PLOS BIOLOGY (2015)
Susceptibility Testing of the Polymyxins: Where Are We Now?
Romney M. Humphries
PHARMACOTHERAPY (2015)
Imipenem, Meropenem, or Doripenem To Treat Patients with Pseudomonas aeruginosa Ventilator-Associated Pneumonia
Charles-Edouard Luyt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
REDUCED ANTIBIOTIC USE IN LIVESTOCK How Denmark Tackled Resistance
Sharon Levy
ENVIRONMENTAL HEALTH PERSPECTIVES (2014)
Genomics of Rapid Adaptation to Antibiotics: Convergent Evolution and Scalable Sequence Amplification
David Laehnemann et al.
GENOME BIOLOGY AND EVOLUTION (2014)
Colistin susceptibility testing: time for a review
Mahableshwar Albur et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
EUCAST expert rules in antimicrobial susceptibility testing
R. Leclercq et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry for Detection of Antibiotic Resistance Mechanisms: from Research to Routine Diagnosis
Jaroslav Hrabak et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections
Burke A. Cunha
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases
M. Baroud et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Change of Antibiotic Susceptibility Testing Guidelines from CLSI to EUCAST: Influence on Cumulative Hospital Antibiograms
Aline Wolfensberger et al.
PLOS ONE (2013)
Correlation between the Consumption of Meropenem or Doripenem and Meropenem Susceptibility of Pseudomonas aeruginosa in a University Hospital in Japan
Koji Miyawaki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)
Sandra Fournier et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2012)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Informed Switching Strongly Decreases the Prevalence of Antibiotic Resistance in Hospital Wards
Roger D. Kouyos et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Antibiotic resistance and its cost: is it possible to reverse resistance?
Dan I. Andersson et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
Michel Doumith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia
Sanjay Merchant et al.
CLINICAL THERAPEUTICS (2008)
Correlation between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a medical-surgical intensive care unit
Hatem Kallel et al.
INDIAN JOURNAL OF CRITICAL CARE MEDICINE (2008)
Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
Javier Ena et al.
UROLOGY (2006)
Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions
Jesus Oteo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values
J Turnidge et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus 2
CD Steward et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus:: Report of a clinical failure
TP Levin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus
SA Grim et al.
PHARMACOTHERAPY (2005)
Antibiotic cycling or rotation: a systematic review of the evidence of efficacy
EM Brown et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units
JM Loeffler et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)